The PI3K/AKT/mTOR pathway plays a critical role in tumor cell survival, proliferation, and immune evasion, often contributing to the creation of an immunosuppressive microenvironment that undermines the efficacy of PD-1 therapy [49]. This evidence concerns the gene MTOR and neoplasm.